Calcium Fructoborate for Bone and Cardiovascular Health

George Dan Mogoşanu, Andrei Biţă, Ludovic Everard Bejenaru, Cornelia Bejenaru, Octavian Croitoru, Gabriela Rău, Otilia-Constantina Rogoveanu, Dan Nicolae Florescu, Johny Neamţu, Iulia Daria Scorei, Romulus Ion Scorei, George Dan Mogoşanu, Andrei Biţă, Ludovic Everard Bejenaru, Cornelia Bejenaru, Octavian Croitoru, Gabriela Rău, Otilia-Constantina Rogoveanu, Dan Nicolae Florescu, Johny Neamţu, Iulia Daria Scorei, Romulus Ion Scorei

Abstract

Calcium fructoborate (CF), a natural sugar-borate ester found in fresh fruits and vegetables, is a source of soluble boron. CF contains three forms of borate (diester, monoester, and boric acid) and all are biologically active, both at the intracellular (as free boric acid) and extracellular level (as fructose-borate diester and monoester). At the cellular and molecular level, CF is superior to the boric acid/borate, exhibiting a complex "protective" effect against inflammatory response. CF is commercially available in the USA as a "nature-identical" complex, an active compound for dietary supplements. It provides effective and safe support against the discomfort and lack of flexibility associated with osteoarticular conditions (arthritis and joint degeneration), and improves Western Ontario and McMaster Universities Osteoarthritis (WOMAC) and McGill indexes. In addition, orally administered CF is effective in ameliorating symptoms of physiological response to stress, including inflammation of the mucous membranes, discomfort associated with osteoarthritis disorders, and bone loss, and also for supporting cardiovascular health. Clinical studies have exhibited the ability of CF to significantly modulate molecular markers associated with inflammatory mechanisms, mainly on the elevated serum levels of C-reactive protein (CRP).

Keywords: Anti-inflammatory activity; Calcium fructoborate; Cardiovascular health; Clinical studies; Cytokines; Sugar-borate esters.

References

    1. Dinca L, Scorei R. Boron in human nutrition and its regulations use. J Nutr Ther. 2013;2:22–29.
    1. Scorei RI, Popa R. Sugar-borate esters—potential chemical agents in prostate cancer chemoprevention. Anticancer Agents Med Chem. 2013;13:901–909. doi: 10.2174/18715206113139990124.
    1. Miljkovic D (1999) Boron carbohydrate complexes and uses thereof. US Patent 5962049 A Oct 1999
    1. Reyes-Izquierdo T, Nemzer B, Gonzalez AE, Zhou Q, Argumedo R, Shu C, Pietrzkowski Z. Short-term intake of calcium fructoborate improves WOMAC and McGill scores and beneficially modulates biomarkers associated with knee osteoarthritis: a pilot clinical double-blinded placebo-controlled study. Am J Biomed Sci. 2012;4:111–122. doi: 10.5099/aj120200111.
    1. Pietrzkowski Z, Phelan MJ, Keller R, Shu C, Argumedo R, Reyes-Izquierdo T. Short-term efficacy of calcium fructoborate on subjects with knee discomfort: a comparative, double-blind, placebo-controlled clinical study. Clin Interv Aging. 2014;9:895–899.
    1. Militaru C, Donoiu I, Craciun A, Scorei ID, Bulearca AM, Scorei RI. Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: effects on lipid profiles, inflammation markers, and quality of life. Nutrition. 2013;29:178–183. doi: 10.1016/j.nut.2012.07.006.
    1. Rogoveanu OC, Mogoşanu GD, Bejenaru C, Bejenaru LE, Croitoru O, Neamţu J, Pietrzkowski Z, Reyes-Izquierdo T, Biţă A, Scorei ID, Scorei RI. Effects of calcium fructoborate on levels of C-reactive protein, total cholesterol, low-density lipoprotein, triglycerides, IL-1β, IL-6, and MCP-1: a double-blind, placebo-controlled clinical study. Biol Trace Elem Res. 2015;163:124–131. doi: 10.1007/s12011-014-0155-9.
    1. Scorei RI, Rotaru P. Calcium fructoborate—potential anti-inflammatory agent. Biol Trace Elem Res. 2011;143:1223–1238. doi: 10.1007/s12011-011-8972-6.
    1. National Academy of Sciences, Institute of Medicine (IoM), Food and Nutrition Board (2001). Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. A Report of the Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and of Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. National Academies Press, Washington, D.C. . Accessed 6 Nov 2015
    1. Scorei RI. Boron-containing compounds, regulation of therapeutic potential. In: Kretsinger RH, Uversky VN, Permyakov EA, editors. Encyclopedia of metalloproteins. New York: Springer; 2013. pp. 301–308.
    1. Bulearca AM, Bita A, Badea F, Patrusca A, Neamtu J, Bejenaru LE, Bejenaru C, Mogosanu GD. Boron analysis from dietary supplements. Rev Chim (Bucharest) 2014;65:84–86.
    1. Rotaru P, Scorei R, Hărăbor A, Dumitru MD. Thermal analysis of a calcium fructoborate sample. Thermochim Acta. 2010;506:8–13. doi: 10.1016/j.tca.2010.04.006.
    1. Edwards JC, Hunter JM, Nemzer BV. Multinuclear NMR of calcium fructoborate complex—structure, stability, and quantitation in the presence of other ingredients, excipients or adulterants. J Food Res. 2014;3:115–131. doi: 10.5539/jfr.v3n3p115.
    1. WHO (World Health Organization) (2003) Population nutrient intake goals for preventing diet-related chronic diseases. . Accessed 5 Sept 2015
    1. Nielsen FH. Evidence for the nutritional essentiality of boron. J Trace Elem Exp Med. 1996;9:215–229. doi: 10.1002/(SICI)1520-670X(1996)9:4<215::AID-JTRA7>;2-P.
    1. Benderdour M, Bui-Van T, Dicko A, Belleville F. In vivo and in vitro effects of boron and boronated compounds. J Trace Elem Med Biol. 1998;12:2–7. doi: 10.1016/S0946-672X(98)80014-X.
    1. Nielsen FH. Is boron nutritionally relevant? Nutr Rev. 2008;66:183–191. doi: 10.1111/j.1753-4887.2008.00023.x.
    1. Scorei ID, Scorei IR. Calcium fructoborate helps control inflammation associated with diminished bone health. Biol Trace Elem Res. 2013;155:315–321. doi: 10.1007/s12011-013-9800-y.
    1. Cui Y, Winton MI, Zhang ZF, Rainey C, Marshall J, De Kernion JB, Eckhert CD. Dietary boron intake and prostate cancer risk. Oncol Rep. 2004;11:887–892.
    1. Scorei R, Ciubar R, Ciofrangeanu CM, Mitran V, Cimpean A, Iordachescu D. Comparative effects of boric acid and calcium fructoborate on breast cancer cells. Biol Trace Elem Res. 2008;122:197–205. doi: 10.1007/s12011-007-8081-8.
    1. Johnson EW, Jayroe LM (2012) Prevention and treatment of osteochondrosis in animals and humans. US Patent 20120328715 A1 Dec 2012
    1. Jugdaohsingh R, Pedro LD, Watson A, Powell JJ. Silicon and boron differ in their localization and loading in bone. Bone Rep. 2015;1:9–15. doi: 10.1016/j.bonr.2014.10.002.
    1. Hunt CD. Dietary boron: progress in establishing essential roles in human physiology. J Trace Elem Med Biol. 2012;26:157–160. doi: 10.1016/j.jtemb.2012.03.014.
    1. Devirian TA, Volpe SL. The physiological effects of dietary boron. Crit Rev Food Sci Nutr. 2003;43:219–231. doi: 10.1080/10408690390826491.
    1. EFSA (European Food Safety Authority) (2004) Opinion of the Scientific Panel on dietetic products, nutrition and allergies on a request from the Commission related to the tolerable upper intake level of boron (sodium borate and boric acid). EFSA J 80:1–22. . Accessed 20 Sept 2015
    1. Scorei R, Cimpoiasu VM, Iordachescu D. In vitro evaluation of the antioxidant activity of calcium fructoborate. Biol Trace Elem Res. 2005;107:127–134. doi: 10.1385/BTER:107:2:127.
    1. Scorei R, Ciubar R, Iancu C, Mitran V, Cimpean A, Iordachescu D. In vitro effects of calcium fructoborate on fMLP-stimulated human neutrophil granulocytes. Biol Trace Elem Res. 2007;118:27–37. doi: 10.1007/s12011-007-0019-7.
    1. Miljkovic D, Scorei RI, Cimpoiaşu VM, Scorei ID. Calcium fructoborate: plant-based dietary boron for human nutrition. J Diet Suppl. 2009;6:211–226. doi: 10.1080/19390210903070772.
    1. Scorei R, Mitrut P, Petrisor I, Scorei I. A double-blind, placebo-controlled pilot study to evaluate the effect of calcium fructoborate on systemic inflammation and dyslipidemia markers for middle-aged people with primary osteoarthritis. Biol Trace Elem Res. 2011;144:253–263. doi: 10.1007/s12011-011-9083-0.
    1. Reyes-Izquierdo T, Phelan MJ, Keller R, Shu C, Argumedo R, Pietrzkowski Z. Short-term efficacy of a combination of glucosamine and chondroitin sulfate compared to a combination of glucosamine, chondroitin sulfate and calcium fructoborate (CFB) on improvement of knee discomfort conditions in healthy subjects. A comparative, double-blind, placebo controlled acute clinical study. J Aging Res Clin Pract. 2014;3:223–228.
    1. Wimmer MA, Lochnit G, Bassil E, Mühling KH, Goldbach HE. Membrane-associated, boron-interacting proteins isolated by boronate affinity chromatography. Plant Cell Physiol. 2009;50:1292–1304. doi: 10.1093/pcp/pcp073.
    1. Harabor A, Rotaru P, Scorei RI, Harabor NA. Non-conventional hexagonal structure for boric acid. J Therm Anal Calorim. 2014;118:1375–1384. doi: 10.1007/s10973-014-4169-5.
    1. Yokota H, Konishi S. Effect of the formation of a sugar-borate complex on the growth inhibition of pollen tubes of Camellia sinensis and cultured cells of Nicotiana tabacum by toxic levels of borate. Soil Sci Plant Nutr. 1990;36:275–281. doi: 10.1080/00380768.1990.10414993.
    1. Zhang W, Ogando DG, Bonanno JA, Obukhov AG. Human SLC4A11 is a novel NH3/H+ co-transporter. J Biol Chem. 2015;290:16894–16905. doi: 10.1074/jbc.M114.627455.
    1. Weerasinghe AJ, Amin SA, Barker RA, Othman T, Romano AN, Parker Siburt CJ, Tisnado J, Lambert LA, Huxford T, Carrano CJ, Crumbliss AL. Borate as a synergistic anion for Marinobacter algicola ferric binding protein, FbpA: a role for boron in iron transport in marine life. J Am Chem Soc. 2013;135:14504–14507. doi: 10.1021/ja406609s.
    1. Park M, Li Q, Shcheynikov N, Muallem S, Zeng W. Borate transport and cell growth and proliferation. Not only in plants. Cell Cycle. 2005;4:24–26. doi: 10.4161/cc.4.1.1394.
    1. Kaya A, Karakaya HC, Fomenko DE, Gladyshev VN, Koc A. Identification of a novel system for boron transport: Atr1 is a main boron exporter in yeast. Mol Cell Biol. 2009;29:3665–3674. doi: 10.1128/MCB.01646-08.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj